跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Norpace Retard 150mg Tablets - TGA Drug Approval Details
Approvals
/
TGA
/
Norpace Retard 150mg Tablets
Approved
STANDARD
Norpace Retard 150mg Tablets
Proqualix Pty Ltd - in Administration
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e27d20fc25d0434f
Company
Proqualix Pty Ltd - in Administration
Type
Standard
Approval Details
Approval Id
e27d20fc25d0434f
Product Name
Norpace Retard 150mg Tablets
Artg Id
32754
Artg Name
Norpace Retard (Disopyramide Base 150mg) Tablets
Sponsor
Proqualix Pty Ltd - in Administration
Artg Date
1991-10-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e27d20fc25d0434f
Type
Standard
Back to TGA Approvals